- Went public (KMDA), Sep 2005
- Raised $60M pipe led by FIMI Opportunity Funds, May 2023
- Raised $25M pipe, Jan 2020
About
Kamada is a plasma-derived protein therapeutics company with a commercial product portfolio and a late-stage clinical pipeline. The company uses its proprietary platform technology and expertise for the extraction and purification of proteins from human plasma.
The company has two FDA-approved products: GLASSIA, intravenous plasma-derived Alpha-1 Antitrypsin (AAT) for the treatment of AAT deficiency, marketed in the United States through a strategic partnership with Shire Plc; and KEDRAB, a rabies immune globulin (human) product distributed in the United States by Kedrion. Kamada also sells an additional four plasma-derived pharmaceutical products in approximately 20 markets.
Kamada has products in late-stage clinical development, including an inhaled formulation of AAT and intravenous AAT for the treatment of type 1 diabetes and GvHD and the prevention of lung transplant rejection.
Funding history · 8 rounds · $150.0M total
Q&A
- What is Kamada's primary business?
- Kamada is a plasma-derived protein therapeutics company with a commercial product portfolio and a late-stage clinical pipeline, specializing in the extraction and purification of proteins from human plasma.
- When was Kamada founded?
- Kamada was founded in December 1990.
- What was Kamada's most recent funding round?
- In May 2023, Kamada completed a PIPE funding round, raising $60,000,000 from FIMI Opportunity Funds.
- What are Kamada's FDA-approved products?
- Kamada has two FDA-approved products: GLASSIA, for the treatment of Alpha-1 Antitrypsin (AAT) deficiency, and KEDRAB, a rabies immune globulin (human) product.
- When did Kamada go public on NASDAQ?
- Kamada went public on NASDAQ in June 2008.
- Which company did Kamada acquire in 2021?
- In February 2021, Kamada acquired Blood and Plasma Research, Inc. for $1,630,000.
- Who is the CEO of Kamada?
- Amir London is the CEO of Kamada.
Team · 4
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | kamada.com |
|---|---|
| linkedin.com/company/117855 | |
| YouTube | youtube.com/channel/UC5xKJDWiNNQU8qnvx9Ch7LA |
| Crunchbase | crunchbase.com/organization/kamada |
Identifiers & details
| Founded | 1990-12 |
|---|---|
| Employees (exact) | 339 |
| Offices | |
| Market cap | $413.9M |
| Status reason | Public on TASE on Sep, 2005;Public on NASDAQ on Jun, 2008; |
Acquisitions & public offerings
| Acquired | Date | Amount |
|---|---|---|
| 2021-02 | $1.6M |
| Type | Date | Exchange | Ticker | Amount |
|---|---|---|---|---|
| 2017-07 | KMDA | $15.0M | ||
| 2008-06 | KMDA | |||
| 2005-09 | KMDA |